EGFR 19 Del的晚期非小细胞肺癌患者一线服用EGFR-TKIs的无进展生存期长于EGFR L858R患者
EGFR 19 Del적만기비소세포폐암환자일선복용EGFR-TKIs적무진전생존기장우EGFR L858R환자
Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer
  • 万方数据
    循证医学 순증의학
    THE JOURNAL OF EVIDENCE-BASED MEDICINE
    2015年 1期 25-28 ,共4页

    黄诚%林根%雷源源

    황성%림근%뢰원원

    非小细胞肺癌%EGFR突变%表皮生长因子受体酪氨酸激酶抑制剂%无进展生存期 非小細胞肺癌%EGFR突變%錶皮生長因子受體酪氨痠激酶抑製劑%無進展生存期
    비소세포폐암%EGFR돌변%표피생장인자수체락안산격매억제제%무진전생존기
    non-small cell lung cancer%EGFR mutation%epidermal growth factor receptor tyrosine kinase inhibitor%progression-free survival


    원문보기 원문다운로드 사이트로이동
저자의 최근 논문